New therapeutics for the prevention and reduction of scarring

Drug Discovery Today

Volumn 13, Issue 21-22, 2008, Pages 973-981

  Occleston, Nick L ^a   O'Kane, Sharon ^a   Goldspink, Nick ^a   Ferguson, Mark W J ^a  

^a Renovo   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; AA 4500; AFIMOXIFENE; ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; AVOTERMIN; AZX 100; CHELASE VIT 100; CONNECTIVE TISSUE GROWTH FACTOR; CORDANEURIN; CORTICOSTEROID; EGS 001; ENZYME INHIBITOR; FG 3019; JUVIDEX; JUVISTA; MEDERMA; NEXAGON; OLIGODEOXYNUCLEOTIDE DERIVATIVE; OLIGONUCLEOTIDE; ONION EXTRACT; OSTEOGENIC PROTEIN 1; POLYPEPTIDE; PR 21S; PREVASCAR; PROCOLLAGEN C PROTEINASE; PUTRESCINE; PYC 35B; RECOMBINANT INTERLEUKIN 10; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA3; SILICONE; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; UK 369930; UK 389228; UK 421045; UK 424134; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CLINICAL TRIAL; COLDS; COMPRESSION GARMENT; DRUG MECHANISM; GENE EXPRESSION; HEADACHE; HUMAN; HYDROGEL; HYPERTROPHIC SCAR; KELOID; LASER SURGERY; MENTAL STRESS; NONHUMAN; PROPHYLAXIS; QUALITY OF LIFE; REGENERATION; REVIEW; SCAR FORMATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANIMALS; CICATRIX; DERMATOLOGIC AGENTS; HUMANS; SKIN;

EID: 54049151889     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.08.009     Document Type: Review

References (88)

1. Singer A.J., et al. Patient priorities with traumatic lacerations. Am. J. Emerg. Med. 18 (2000) 683-686
2. Lowe T., and Paoloni R. Sutured wounds: factors associated with patient-rated cosmetic scores. Emerg. Med. Australas. 18 (2006) 259-267
3. Crossland D.S., et al. Patient attitudes to sternotomy and thoracotomy scars. Thorac. Cardiovasc. Surg. 53 (2005) 93-95
4. Bock O., et al. Quality of life of patients with keloid and hypertrophic scarring. Arch. Dermatol. Res. 297 (2006) 433-438
5. Levine E., et al. Quality of life and facial trauma: psychological and body image effects. Ann. Plast. Surg. 54 (2005) 502-510
6. Bayat A., et al. Skin scarring. BMJ 326 (2003) 88-92
7. Dixon A.J., et al. Prospective study of long-term patient perceptions of their skin cancer surgery. J. Am. Acad. Dermatol. 57 (2007) 445-453
8. Li-Tsang C.W., et al. Prevalence of hypertrophic scar formation and its characteristics among the Chinese population. Burns 31 (2005) 610-616
9. Robert R., et al. Disfiguring burn scars and adolescent self-esteem. Burns 25 (1999) 581-585
10. Lawrence J.W., et al. Visible vs hidden scars and their relation to body esteem. J. Burn Care Rehabil. 25 (2004) 25-32
11. Bayat A., and McGrouther D.A. Clinical management of skin scarring. Skinmed 4 (2005) 165-173
12. Newell R. Psychological difficulties amongst plastic surgery ex-patients following surgery to the face: a survey. Br. J. Plast. Surg. 53 (2000) 386-392
13. Layton A.M. Optimal management of acne to prevent scarring and psychological sequelae. Am. J. Clin. Dermatol. 2 (2001) 135-141
14. Valente S.M. Visual disfigurement and depression. Plast. Surg. Nurs. 24 (2004) 140-146
15. Rumsey N., et al. Exploring the psychosocial concerns of outpatients with disfiguring conditions. J. Wound Care 12 (2003) 247-252
16. McGrouther D.A. Facial disfigurement. BMJ 314 (1997) 991
17. Tebble N.J., et al. Anxiety and self-consciousness in patients with minor facial lacerations. J. Adv. Nurs. 47 (2004) 417-426
18. Partridge J. Facial disfigurement. Both counselling for patients and education for the public are necessary. BMJ 315 (1997) 120
19. Shepherd J.P., et al. Psychological distress after assaults and accidents. BMJ 301 (1990) 849-850
20. Bisson J.I., et al. Psychological sequelae of facial trauma. J. Trauma 43 (1997) 496-500
21. Tebble N.J., et al. Anxiety and self-consciousness in patients with facial lacerations one week and six months later. Br. J. Oral. Maxillofac. Surg. 44 (2006) 520-525
22. Abu-Nab Z., and Grunfeld E.A. Satisfaction with outcome and attitudes towards scarring among women undergoing breast reconstructive surgery. Patient Educ. Couns. 66 (2007) 243-249
23. Stewart K.J., et al. Complications of 278 consecutive abdominoplasties. J. Plast. Reconstr. Aesthet. Surg. 59 (2006) 1152-1155
24. Bragg T.W., et al. Patient satisfaction following abdominoplasty: an NHS experience. J. Plast. Reconstr. Aesthet. Surg. 60 (2007) 75-78
25. Mustoe T.A., et al. International clinical recommendations on scar management. Plast. Reconstr. Surg. 110 (2002) 560-571
26. Humphreys T.R. Perioperative management of patient expectations. Skinmed 4 (2005) 379-380
27. Scar Reduction and Wound Healing Global Opportunity Research. Quantitative and Qualitative Research Among US Physicians and Patients. 2005
28. Franz M.G., et al. Optimizing healing of the acute wound by minimizing complications. Curr. Probl. Surg. 44 (2007) 691-763
29. Batra R.S. Surgical techniques for scar revision. Skin Ther. Lett. 10 (2005) 4-7
30. Meier K., and Nanney L.B. Emerging new drugs for scar reduction. Expert. Opin. Emerg. Drugs 11 (2006) 39-47
31. Berman B., et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol. Surg. 33 (2007) 1291-1302
32. Aarabi S., et al. Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med. 4 (2007) e234
33. Shih R., et al. Review of over-the-counter topical scar treatment products. Plast. Reconstr. Surg. 119 (2007) 1091-1095
34. O'Brien, L., and Pandit, A. (2006) Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst. Rev., CD003826
35. Slemp A.E., and Kirschner R.E. Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr. Opin. Pediatr. 18 (2006) 396-402
36. Ferguson M.W., and O'Kane S. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359 (2004) 839-850
37. Ferguson M.W., et al. Scar formation: the spectral nature of fetal and adult wound repair. Plast. Reconstr. Surg. 97 (1996) 854-860
38. Longaker M.T., et al. Adult skin wounds in the fetal environment heal with scar formation. Ann. Surg. 219 (1994) 65-72
39. Whitby D.J., and Ferguson M.W. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 112 (1991) 651-668
40. Whitby D.J., and Ferguson M.W. Immunohistochemical localization of growth factors in fetal wound healing. Dev. Biol. 147 (1991) 207-215
41. Chen W., et al. Ontogeny of expression of transforming growth factor-β and its receptors and their possible relationship with scarless healing in human fetal skin. Wound Repair. Regen. 13 (2005) 68-75
42. Mustoe T.A., et al. Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237 (1987) 1333-1336
43. Robinson B.W., and Goss A.N. Intra-uterine healing of fetal rat cheek wounds. Cleft Palate J. 18 (1981) 251-255
44. Shah M., et al. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107 (1994) 1137-1157
45. Shah M., et al. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108 (1995) 985-1002
46. O'Kane S., and Ferguson M.W.J. Transforming growth factor betas and wound healing. Int. J. Biochem. Cell Biol. 29 (1997) 63-78
47. Singer A.J., and Clark R.A. Cutaneous wound healing. N. Engl. J. Med. 341 (1999) 738-746
48. Liechty K.W., et al. Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J. Pediatr. Surg. 35 (2000) 866-872
49. Fiorentino D.F.J., et al. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. Immunology 146 (1991) 3444-3451
50. Bogdan C., et al. Macrophage deactivation by interleukin 10. J. Exp. Med. 174 (1991) 1549-1555
51. Nakagome K., et al. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung. Thorax 61 (2007) 886-894
52. Yamamoto T., et al. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1. Biochem Biophys Res Commun 281 (2001) 200-205
53. Reitamo S., et al. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J. Clin. Invest. 94 (1994) 2489-2492
54. Arai T., et al. Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (2000) L914-L922
55. Sato Y., et al. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem. Biophys. Res. Commun. 265 (1999) 194-199
56. Peranteau W.H., et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J. Invest. Dermatol. 128 (2008) 1852-1860
57. Nakagome K., et al. In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by down-regulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation. J. Immunol. 174 (2005) 6955-6966
58. Sibille M., et al. Adverse events in phase-I studies: a report in 1015 healthy volunteers. Eur. J. Clin. Pharmacol. 54 (1998) 13-20
59. Rosenzweig P., et al. The placebo effect in healthy volunteers: influence of experimental conditions on the adverse events profile during phase I studies. Clin. Pharmacol. Ther. 54 (1993) 578-583
60. Sibille M., et al. Intercurrent disease in healthy volunteers in pharmacological research. Lancet 339 (1992) 1058
61. Murphy M.O., et al. In vivo attenuation of myointimal hyperplasia using transforming growth factor-beta3 in an interposition graft model. J. Endovasc. Ther. 13 (2006) 389-399
62. Ghosh J., et al. Reduction of myointimal hyperplasia after arterial anastomosis by local injection of transforming growth factor beta3. J. Vasc. Surg. 43 (2006) 142-149
63. Atkins S., et al. Interleukin-10 reduces scarring and enhances regeneration at a site of sciatic nerve repair. J. Peripher. Nerv. Syst. 12 (2007) 269-276
64. Chung V.Q., et al. Onion extract gel versus petrolatum emollient on new surgical scars: prospective double-blinded study. Dermatol. Surg. 32 (2006) 193-197
65. Jalali M., et al. Current use of steroids in management of abnormal raised skin scars. Surgeon 5 (2007) 175-180
66. Van den Kerckhove E., et al. The assessment of erythema and thickness on burn related scars during pressure garment therapy as a preventive measure for hypertrophic scarring. Burns 31 (2005) 696-702
67. Reiffel R.S. Prevention of hypertrophic scars by long-term paper tape application. Plast. Reconstr. Surg. 96 (1995) 1715-1718
68. Davey R.B., et al. Adhesive contact media- an update on graft fixation and burn scar management. Burns 17 (1991) 313-319
69. Gold M.H. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J. Am. Acad. Dermatol. 30 (1994) 506-507
70. Gold M.H., et al. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol. Surg. 27 (2001) 641-644
71. Li-Tsang C.W., et al. A prospective randomized clinical trial to investigate the effect of silicone gel sheeting (Cica-Care) on post-traumatic hypertrophic scar among the Chinese population. Burns 32 (2006) 678-683
72. Jih M.H., et al. Successful treatment of a chronic atrophic dog-bite scar with the 1450-nm diode laser. Dermatol. Surg. 30 (2004) 1161-1163
73. Friedman P.M., et al. Treatment of inflammatory facial acne vulgaris with the 1450-nm diode laser: a pilot study. Dermatol. Surg. 30 (2004) 147-151
74. Alster T. Laser scar revision: comparison study of 585-nm pulsed dye laser with and without intralesional corticosteroids. Dermatol. Surg. 29 (2003) 25-29
75. Alster T.S. Clinical and histologic evaluation of six erbium: YAG lasers for cutaneous resurfacing. Lasers Surg. Med. 24 (1999) 87-92
76. Chen J.S., et al. A comparison of scar revision with the free electron and carbon dioxide resurfacing lasers. Plast. Reconstr. Surg. 108 (2001) 1268-1275
77. Tse Y., et al. A clinical and histologic evaluation of two medium-depth peels. Glycolic acid versus Jessner's trichloroacetic acid. Dermatol. Surg. 22 (1996) 781-786
78. Wainwright D., et al. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns. J. Burn. Care Rehabil. 17 (1996) 124-136
79. Heimbach D., et al. Artificial dermis for major burns. A multi-center randomized clinical trial. Ann. Surg. 208 (1988) 313-320
80. Carsin H., et al. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: a five year single-center experience with 30 patients. Burns 26 (2000) 379-387
81. Compton C.C. Current concepts in pediatric burn care: the biology of cultured epithelial autografts: an eight-year study in pediatric burn patients. Eur. J. Pediatr. Surg. 2 (1992) 216-222
82. Qiu C., et al. Targeting connexin43 expression accelerates the rate of wound repair. Curr. Biol. 13 (2003) 1697-1703
83. Cho, Y.J. et al. (2004) New composition comprising bone morphogenetic protein-7 (BMP-7) polypeptide, useful for inhibiting the formation of scar, e.g. corneal scar, and for preventing fibrosis of various internal organs. Patent WO2004060388-A1
84. Sisco M., et al. Antisense inhibition of connective tissue growth (CTGF/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Rep Regen. 16 (2008) 661-673
85. Onose G., et al. Recent advancements in biomaterials for spinal cord injury complex therapeutics. Dig. J. Nanomater. Biostruct. 2 (2007) 307-314
86. Fish P.V., et al. Potent and selective nonpeptidic inhibitors of procollagen C-proteinase. J. Med. Chem. 50 (2007) 3442-3456
87. Yamada H., et al. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J. Biochem. 116 (1994) 892-897
88. Isaji M., et al. Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoyl)anthranilic acid (N-5′) in granulation tissue. Biochem. Pharmacol. 36 (1987) 469-474